海普瑞(002399)

社区社区
资讯资讯
资料资料
公告公告

- 最新
- 推荐
公司概况
公司名称
深圳市海普瑞药业集团股份有限公司
所属行业
医药制造业
上市日期
2010-05-06
注册资本
146729万元
公司概况
深圳市海普瑞药业集团股份有限公司的主营业务是肝素产业链，生物大分子CDMO和创新药物的投资，开发及商业化。公司的主要产品是依诺肝素钠制剂、肝素钠和依诺肝素钠原料药、分子药物CDMO服务。

暂不提供行情数据

热议股票

{"pagemeta":{"title":"海普瑞(002399)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供海普瑞(002399)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"海普瑞,002399,海普瑞股票,海普瑞股票老虎,海普瑞股票老虎国际,海普瑞行情,海普瑞股票行情,海普瑞股价,海普瑞股市,海普瑞股票价格,海普瑞股票交易,海普瑞股票购买,海普瑞股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"海普瑞(002399)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供海普瑞(002399)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}},"tab":"summary","symbol":"002399","data":{"stockData":{"symbol":"002399","market":"SZ","secType":"STK","nameCN":"海普瑞","latestPrice":10.4,"timestamp":1779174192000,"preClose":10.16,"halted":0,"volume":4307700,"delay":0,"changeRate":0.0236,"floatShares":1247000000,"shares":1467000000,"eps":0.2593,"marketStatus":"已收盘","change":0.24,"latestTime":"05-19 15:00:00","open":10.16,"high":10.43,"low":10.14,"amount":44410200,"amplitude":0.0285,"askPrice":10.41,"askSize":278,"bidPrice":10.4,"bidSize":58,"shortable":0,"etf":0,"ttmEps":0.2593,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1779240600000},"marketStatusCode":5,"adr":0,"adjPreClose":10.16,"symbolType":"stock","openAndCloseTimeList":[[1779154200000,1779161400000],[1779166800000,1779174000000]],"highLimit":11.18,"lowLimit":9.14,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1467296204,"isCdr":false,"pbRate":1.22,"roa":"--","peRate":40.107983,"roe":"1.55%","epsLYR":0.2382,"committee":-0.162521,"marketValue":15260000000,"turnoverRate":0.0035,"status":0,"hkstockBrief":{"symbol":"09989","market":"HK","secType":"STK","nameCN":"海普瑞","latestPrice":4.6,"timestamp":1779178099177,"preClose":4.55,"halted":0,"volume":469000,"delay":0,"premium":"-61.51"},"floatMarketCap":12971000000},"tweetData":null,"newsData":null,"noticeData":{"listData":[],"currentPage":1,"bottom":true},"companyData":{"profile":null,"aProfile":{"ret":0,"serverTime":1779216202730,"stockEarnings":[{"period":"1week","weight":-0.0189},{"period":"1month","weight":-0.0647},{"period":"3month","weight":-0.1369},{"period":"6month","weight":-0.1384},{"period":"1year","weight":-0.0668},{"period":"ytd","weight":-0.1179}],"compareEarnings":[{"period":"1week","weight":-0.0107},{"period":"1month","weight":0.0292},{"period":"3month","weight":0.0214},{"period":"6month","weight":0.0607},{"period":"1year","weight":0.2381},{"period":"ytd","weight":0.0506}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"深圳市海普瑞药业集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"0人","perCapita":"--","listingDate":"2010-05-06","address":"广东省深圳市南山区松坪山郎山路21号","registeredCapital":"146729万元","survey":"　　深圳市海普瑞药业集团股份有限公司的主营业务是肝素产业链，生物大分子CDMO和创新药物的投资，开发及商业化。公司的主要产品是依诺肝素钠制剂、肝素钠和依诺肝素钠原料药、分子药物CDMO服务。","listedPrice":148}}}}

海普瑞(002399)

公司概况

热议股票